Tech Company Financing Transactions

AbCellera Funding Round

AbCellera closed a $10 million Series A financing round on 9/28/2018. Investors included Data Collective and private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A

Data Collective (Lead Investor) (John Hamer)

Proceeds Purpose
AbCellera will use financing to accelerate the growth of their therapeutic antibody discovery business, including investments to build capacity and integration of advanced technological capabilities spanning computation, protein engineering, and immune repertoire profiling.

Company Information

Company Status
Mailing Address
2215 Yukon St.
Vancouver BC, V5Y 0A1
Email Address
AbCellera Biologics (Nasdaq: ABCL) With the world's leading technology for screening and mapping of natural immune responses, we test antibodies from single B cells at depths of millions of cells per day. We unlock the power of natural immunity to discover the next generation of antibody therapies.
AbCellera LinkedIn Company Profile
Social Media
AbCellera Company Twitter Account
Company News
AbCellera News
AbCellera on Facebook
AbCellera on YouTube

Management Team

Email & Social
Chief Executive Officer
Carl Hansen
  Carl Hansen LinkedIn Profile  Carl Hansen Twitter Account  Carl Hansen News  Carl Hansen on Facebook
Chief Financial Officer
Andrew Booth
  Andrew Booth LinkedIn Profile  Andrew Booth Twitter Account  Andrew Booth News  Andrew Booth on Facebook
Chief Operating Officer
Véronique Lecault
  Véronique Lecault LinkedIn Profile  Véronique Lecault Twitter Account  Véronique Lecault News  Véronique Lecault on Facebook
Chief Scientific Officer
Bo Barnhart
  Bo Barnhart LinkedIn Profile  Bo Barnhart Twitter Account  Bo Barnhart News  Bo Barnhart on Facebook
VP - Bus. Development
Graham Craig
  Graham Craig LinkedIn Profile  Graham Craig Twitter Account  Graham Craig News  Graham Craig on Facebook
VP - Bus. Development
Kevin Heyries
  Kevin Heyries LinkedIn Profile  Kevin Heyries Twitter Account  Kevin Heyries News  Kevin Heyries on Facebook
VP - Bus. Development
Murray McCutcheon
  Murray McCutcheon LinkedIn Profile  Murray McCutcheon Twitter Account  Murray McCutcheon News  Murray McCutcheon on Facebook
VP - Finance
Marcie Thiessen
  Marcie Thiessen LinkedIn Profile  Marcie Thiessen Twitter Account  Marcie Thiessen News  Marcie Thiessen on Facebook
VP - General Counsel
Tryn Stimart
  Tryn Stimart LinkedIn Profile  Tryn Stimart Twitter Account  Tryn Stimart News  Tryn Stimart on Facebook
VP - R & D
Ester Falconer
  Ester Falconer LinkedIn Profile  Ester Falconer Twitter Account  Ester Falconer News  Ester Falconer on Facebook



Browse more venture capital transactions:

Prev: 9/28/2018: Source Defense venture capital transaction
Next: 9/28/2018: Xilio Therapeutics venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary